Can Fibre Lower HbA1c by 1%? What Experts Say

Managing diabetes with 10 to 12 grams of daily soluble fiber can significantly reduce post-meal sugar spikes and lower HbA1c levels, according to nutritionist Dr. Rebecca Pinto, though endocrinologist Dr. Himika Chawla emphasizes that fiber works best alongside balanced meals, regular exercise, and medical treatment rather than serving as a standalone cure. Can Soluble Fibre … Read more

PPAR Receptors: A New Therapeutic Target for Rare Liver Disease

Primary biliary cholangitis is a rare autoimmune disease affecting small bile ducts within the liver, causing bile to build up and trigger progressive liver damage that can eventually lead to cirrhosis, according to recent medical studies. Because the immune system attacks these vital ducts, roughly 40% of patients fail to respond adequately or cannot tolerate … Read more

Is Coffee Good for Your Heart? The Surprising Truth About Caffeine

Caffeine Consumption and Heart Health: What the Latest Science Says Moderate caffeine intake—defined as up to 400 mg daily, or roughly three to five 8-ounce cups of black coffee—is generally safe for most adults and may be linked to a lower risk of cardiovascular conditions like stroke and heart failure, according to a recent scientific … Read more

GLP-1 Receptor Activation Linked to Reduced Depression, Bipolar Disorder Risk

Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more

GLP-1 Drugs in Pregnancy: Do They Increase Birth Defect Risk?

A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more

Medicare Wegovy Prescriptions Surge Following Heart Disease Coverage Expansion

Medicare prescriptions for the anti-obesity medication Wegovy surged 598% in the six months following a federal policy shift that allowed coverage for heart disease prevention. Despite this increase, new research from the USC Schaeffer Center for Health Policy & Economics reveals that less than 1% of the estimated 3.6 million eligible beneficiaries have accessed the … Read more

Combine Strength Training and Cardio to Slash Type 2 Diabetes Risk

Consistently performing resistance training at least twice a week significantly lowers the long-term risk of type 2 diabetes (T2D), according to a prospective cohort study published in JAMA Network Open. Researchers analyzing data from 143,715 healthcare professionals found that participants who combined strength training with aerobic activity and limited sedentary time, such as television viewing, … Read more

Modified Mediterranean Diet Linked to Longer Lifespan: USC Study

A plant-forward, low-protein diet supplemented with precise amounts of the amino acid methionine increases healthspan and reduces frailty in mice, according to a study published in Cell Metabolism by researchers at the University of Southern California (USC). Led by Valter Longo of the USC Leonard Davis School of Gerontology, the team found that balancing specific … Read more

Onion-Loving Gene Linked to Lower Diabetes and Blood Pressure Risk

A new study published in BMC Medicine reveals that a specific genetic variant linked to a preference for onions is associated with lower blood pressure and a 14% reduced risk of type 2 diabetes. Researchers from the Monell Chemical Senses Center and their international partners used Mendelian randomization to determine that these genetic markers act … Read more

GLP-1 Drugs: Study Highlights Frequent Stop-and-Start Patterns

Nearly 4 in 10 patients with type 2 diabetes stop their GLP-1 medication within the first year of treatment, according to research presented at the Endocrine Society’s annual meeting, ENDO 2026. While discontinuation rates climb to nearly 6 in 10 by the end of two years, the data reveals a high frequency of patients restarting … Read more